ロード中...
Early Disease Activity or Clinical Response as Predictors of Long‐Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis
OBJECTIVE: Early identification of patients unlikely to achieve good long‐term disease control with anti–tumor necrosis factor therapy in axial spondyloarthritis (SpA) and psoriatic arthritis (PsA) is important for physicians following treat‐to‐target recommendations. Here we assess associations bet...
保存先:
| 出版年: | Arthritis Care Res (Hoboken) |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518306/ https://ncbi.nlm.nih.gov/pubmed/27696727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23092 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|